Drug
Abaloparatide clinical trials
Also written Tymlos and BA058.
- studies test it
- 15
- open now
- 1
- in phase 3
- 4
- first study started
- 2007
Keep track of what changes. Save the abaloparatide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2019 (3)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2011 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 6
- Phase 3
- 4
- Phase 4
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 9
Radius Health, Inc. (6) · Hospital for Special Surgery, New York (3) · University of Wisconsin, Madison (1) · University of Rochester (1) · State University of New York at Buffalo (1) · David Lunardini (1) · Daniel Horwitz (1) · Johns Hopkins University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses abaloparatide is read from its arms, and is right about nine times in ten.
Testing it · 15
- The Effect of Osteoporotic Medications on Vertebral Bone Quality ScoreEnrolling by invitationPhase 2State University of New York at BuffaloNCT07587775Written as Abaloparatide
- Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab AloneActive, not recruitingPhase 4Hospital for Special Surgery, New YorkNCT04467983Written as Abaloparatide
- Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion SurgeryActive, not recruitingPhase 2Hospital for Special Surgery, New YorkNCT03841058Written as Abaloparatide
- Abaloparatide Before Total Knee ArthroplastyCompletedPhase 4University of Wisconsin, MadisonNCT04167163Written as Abaloparatide
- PTH Analog Type II Odontoid FractureTerminatedPhase 2David LunardiniNCT04760782Written as Abaloparatide
- Abaloparatide and Pelvic Fracture HealingCompletedPhase 2Hospital for Special Surgery, New YorkNCT04249232Written as Abaloparatide 80 micrograms per Pen dose
- Supracondylar Distal Femur Fractures and AbaloparatideWithdrawnPhase 4Daniel HorwitzNCT04626141Written as Abaloparatide
- Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)CompletedPhase 3Radius Health, Inc.NCT03512262Written as Abaloparatide
- Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With OsteoporosisCompletedPhase 3Radius Health, Inc.NCT04064411Written as abaloparatide
- A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic SyndromesCompletedPhase 1University of RochesterNCT03746041Written as abaloparatide
- Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women.CompletedPhase 1Radius Health, Inc.NCT04663464Written as abaloparatide-SC
- Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and ResorptionCompletedPhase 3Radius Health, Inc.NCT03710889Written as Abaloparatide
- Effect of Abaloparatide on Lumbar Disc DegenerationWithdrawnPhase 2Johns Hopkins UniversityNCT03708926Written as Abaloparatide
- Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With OsteoporosisCompletedPhase 2Radius Health, Inc.NCT00542425Written as BA058 20 µg
- Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal WomenCompletedPhase 3Radius Health, Inc.NCT01343004Written as BA058 80 mcg
As the comparator · 1 — what is tested is compared with abaloparatide
Codes
What other systems call abaloparatide · ClinicalTrials.gg INT000202
- MeSH (NLM) C000596789abaloparatideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) AVK0I6HY2UABALOPARATIDEConfirmed FDA, NLM, Wikidata
- RxNorm 1921069Confirmed FDA, Wikidata
- Wikidata Q4834481abaloparatideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C158818AbaloparatideOne source FDA
- DrugBank DB05084One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000596789 | abaloparatide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | AVK0I6HY2U | ABALOPARATIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1921069 | — | Confirmed FDA, Wikidata |
| Wikidata | Q4834481 | abaloparatide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C158818 | Abaloparatide | One source FDA |
| DrugBank | DB05084 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.